Clinical Problem
Spinal cord and peripheral nerve injuries face poor intrinsic regeneration, inhibitory injury environments, loss of electrical signaling, and functional deficits that conventional repair approaches cannot reliably reverse.
Advanced Bioelectric Nerve Implant
An electroceutical cryogel scaffold that guides nerve regrowth with structure and electrical cues.
ElectroGel combines reduced graphene oxide functionalized aligned cryogels with intraoperative electrical stimulation to support spinal cord and peripheral nerve regeneration.
rGO
Conductive scaffold
80%
Related nerve wrap recovery
CTRI
Clinical approval milestone
Mechanism
Aligned cryogels mimic longitudinal nerve tracts, while reduced graphene oxide adds conductivity. Electrical stimulation stabilizes injured nerve ends and supports regenerative signaling.
Material Platform
Reduced graphene oxide functionalized aligned cryogels, plus learnings from nerve wraps, 3D printed guidance conduits, and exosome-polypyrrole/liposome systems.
Proof & Translation
Resources describe spinal cord compression and transection models with exuberant nerve-fiber growth and desired functional recovery; related nerve-wrap work reported 80% functional recovery within 8 weeks.
How It Works
Simulation Linked01
Bridge
Aligned cryogel architecture offers physical guidance through the injury zone.
02
Conduct
Reduced graphene oxide helps mimic the bioelectric character of nerve tissue.
03
Stimulate
In-situ stimulation supports neuroprotection, neuro-regeneration, and neuroplasticity.
Why It Matters
- Combines regenerative medicine with electroceutical logic
- Designed for spinal cord compression and transection injury contexts
- Topographical and electrical cues in one implantable platform
- Clinical-trial translation milestone already described in resources
Translation Status
Current Status: Test Manufacturing License and CTRI approval granted for clinical trials